Zimbabwe has turned down a substantial American health deal valued at $367m (272 million pounds) spanning five years because of the United States' demand for sensitive information.
This move was revealed following a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the deal was "lopsided".
A government spokesperson later explained that the United States was seeking health data for research and commercial purposes while was unwilling to guarantee the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged continued negotiations to find a deal agreeable to all parties so the country's critical HIV treatment initiative can continue.
Wider Background
This development comes after a similar situation in Kenya, where a court blocked a similar deal with the US following concerns were filed about the safety of Kenyans' medical information.
After returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump claimed its spending was "inefficient" and his government was seeking direct bilateral deals to enhance transparency and responsibility.
As per reports, Sixteen African countries have so far agreed to similar health pacts, constituting over $18.3bn in committed funds.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to share its biological resources and data for a long time, with no equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that might result from that provided information," he stated.
"In essence, our country would supply the basic resources for scientific discovery with no certainty that the end products would be accessible to our population if a new health crisis emerge."
National Interest and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were upending structures previously set up through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage future pandemics.
"This framework is designed to guarantee that when a country contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to further discussions with our American counterparts on how subsequent co-operation could be structured in a manner that respects the sovereignty and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but urged that negotiations must proceed considering much of the nation's Aids initiatives depended on international support.
"If technical issues exist, such as those relating to data governance or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," it commented.
The halted deal highlights the continuing debate between accepting much-needed foreign assistance and protecting local interests in an increasingly data-driven world.